Related Experiment Video
Updated: Jun 3, 2026

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors
Published on: September 27, 2019
Mediators of pruritus during cholestasis
Ronald P J Oude Elferink1, Andreas E Kremer, Ulrich Beuers
1Tytgat Institute for Liver and Intestinal Research, Academic Medical Center, Amsterdam, The Netherlands. r.p.oude-elferink@amc.uva.nl
Cholestatic liver disease causes severe itching due to increased lysophosphatidic acid (LPA). Elevated autotaxin enzyme activity leads to higher LPA levels, activating nerve fibers and causing pruritus in patients.
Area of Science:
- Hepatology
- Neuroscience
- Biochemistry
Background:
- Pruritus is a debilitating symptom in cholestatic liver diseases, significantly impacting patient quality of life.
- The precise molecular mechanisms underlying cholestasis-induced itch remain largely elusive.
- Previous hypotheses involving bile salts and opioids have lacked definitive proof.
Purpose of the Study:
- To investigate the molecular mediators responsible for pruritus in cholestatic liver diseases.
- To identify novel compounds in cholestatic patient plasma that activate neuronal signaling pathways.
Main Methods:
- Screening of plasma compounds from cholestatic patients for neuronal activation.
- Quantification of lysophosphatidic acid (LPA) and autotaxin levels in patient samples.
- Intradermal injection of LPA in mice to assess its effect on scratching behavior.
Main Results:
- Lysophosphatidic acid (LPA) was identified as a potent activator of neuronal cell lines in cholestatic patient plasma.
- Significantly higher LPA levels were found in the plasma of patients experiencing pruritus.
- Elevated serum autotaxin, the enzyme producing LPA, correlated with increased LPA concentrations.
Conclusions:
- Increased autotaxin expression during cholestasis leads to elevated local LPA formation.
- LPA activates specific LPA receptors on sensory nerve fibers, potentiating itch signals.
- This pathway provides a novel molecular explanation for pruritus in cholestatic liver diseases.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Cholinergic Antagonists: Pharmacokinetics
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Hepatic Drug Excretion: Influencing Factors
Cholecystitis
Direct-Acting Cholinergic Agonists: Therapeutic Uses